Exhibit at the ESHRE 38th Annual Meeting

12 May 2022

ESHRE is excited at the prospect of getting back together in a live setting and picking up where we left off two years ago, with our 38th Annual Meeting, taking place in Milan, form 3 to 6 July. As an exhibitor/sponsor you will have the opportunity to meet and network with new and old customers, have great visibility allowing you to expand your global reach.
Exhibit bookings will close on 27 May 2022!

To err is human, also in MAR

25 April 2022

Error management is an essential part of the total quality management system in Medically Assisted Reproduction (MAR), however, the data on how to tackle this in MAR is scarce.
ESHRE is committed to filling the gap with good practice recommendations on how to deal with errors in MAR. I order to be able to give a good overview of the current practices, we invite you to participate in this 10 minute survey related to aspects of error management.

Take part in the research for the update of the POI guideline - complete a 10 minute survey

08 April 2022

The European Society of Human Reproduction and Embryology (ESHRE), The American Society for Reproductive Medicine (ASRM), The International Menopause Society (IMS) and The Centre of Research Excellence - Women's Health in Reproductive Life (CRE-WHiRL) have come together in an international collaboration to update the 2016 ESHRE Premature Ovarian Insufficiency (POI) guideline.
As co-chairs of the guideline development group, we invite you to take part in this ethics approved research about the content, resources and tools for the new POI guideline, and to share your opinions as a health professional caring for women with POI.

Latest update and actions ESHRE has undertaken

10 March 2022

ESHRE is acknowledging the reproductive medical emergency in Ukraine. Fertility services could easily discontinue their elective ART treatments, and while patients find refuge, the safeguarding of all stored gametes and embryos can no longer be guaranteed in the light of rapidly unfolding events. Tens of thousands of infertile couples and individuals that have pursued oncology and fertility cryopreservation have stored reproductive material in the numerous ART clinics in Ukraine.
Such stored material is now at risk of demise due to lack of monitoring, security and continuous provision of liquid nitrogen.
ESHRE has taken the initiative to help clinics in Ukraine and neighboring countries identify pathways to safely move the stored gametes and embryos -with the appropriate documentation- outside of the conflict zone to safe European Tissue Establishments who are willing to accept them.